HRT Financial’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-13,592
| Closed | -$685K | – | 2687 |
|
|
2024
Q3 | $685K | Buy |
+13,592
| New | +$685K | ﹤0.01% | 1326 |
|
|
2024
Q2 | – | Sell |
-31,941
| Closed | -$1.6M | – | 2572 |
|
|
2024
Q1 | $1.6M | Buy |
31,941
+16,650
| +109% | +$836K | 0.01% | 645 |
|
|
2023
Q4 | $923K | Buy |
+15,291
| New | +$923K | 0.01% | 955 |
|
|
2022
Q1 | – | Sell |
-14,258
| Closed | -$141K | – | 3257 |
|
|
2021
Q4 | $141K | Buy |
14,258
+7
| +0% | +$69 | ﹤0.01% | 2383 |
|
|
2021
Q3 | $140K | Sell |
14,251
-7
| -0% | -$69 | ﹤0.01% | 2537 |
|
|
2021
Q2 | $147K | Hold |
14,258
| – | – | ﹤0.01% | 2395 |
|
|
2021
Q1 | $146K | Hold |
14,258
| – | – | ﹤0.01% | 2160 |
|
|
2020
Q4 | $154K | Buy |
+14,258
| New | +$154K | ﹤0.01% | 1493 |
|